Skip to main content
Clinical Trials/CTRI/2022/04/042199
CTRI/2022/04/042199
Not Yet Recruiting
N/A

Metabolic syndrome in patients with childhood psoriasis

Pandit BD Sharma PGIMS Rohtak0 sites0 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Pandit BD Sharma PGIMS Rohtak
Status
Not Yet Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Pandit BD Sharma PGIMS Rohtak

Eligibility Criteria

Inclusion Criteria

  • Newly diagnosed patients of stable chronic plaque psoriasis in the age group of 10\-18yrs

Exclusion Criteria

  • Children under age of 10 years
  • Adults more than 18 years
  • Patients with other skin diseases known to be associated with metabolic syndrome such as vitiligo, acanthosis nigricans, lichen planus, androgenetic alopecia and systemic lupus erythematosus.
  • Patients with history of smoking and alcoholism.
  • Patients receiving systemic therapy for psoriasis like systemic retinoids, immunosuppressants for at least 6 weeks and any topical therapy for 4 weeks prior to enrollment in the study.
  • Patients taking other medications known to cause hyperglycemia, hypertension and hyperlipidemia within 72 hours prior to enrollment in the study.
  • Patients with history of endocrine disease like cushing disease, acromegaly, phaeochromocytoma, hyperthyroidism, glucagonoma.

Outcomes

Primary Outcomes

Not specified

Similar Trials